Structure and regulation of mammalian squalene synthase.

Mammalian squalene synthase (SQS) catalyzes the first reaction of the branch of the isoprenoid metabolic pathway committed specifically to sterol biosynthesis. SQS produces squalene in an unusual two-step reaction in which two molecules of farnesyl diphosphate are condensed head-to-head. Recent studies have advanced understanding of the reaction mechanism, the functional domains of the enzyme, and transcriptional regulation of the gene. Site-directed mutagenesis has identified conserved Asp, Tyr, and Phe residues that are essential for SQS activity. The Asp residues are hypothesized to be required for substrate binding; the Tyr and Phe residues may stabilize carbocation reaction intermediates. The elucidation of SQS crystal structure will most likely direct future research on the relationship between enzyme structure and function. SQS activity, protein, and mRNA levels are regulated by cholesterol status and by the cytokines TNF-alpha and IL-1beta. Activation of the SQS promoter in response to cholesterol deficit is mediated by sterol regulatory element binding proteins SREBP-1a and SREBP-2. The precise contributions made by individual SREBPs and accessory transcription factors to SQS transcriptional control, and the mechanisms underlying cytokine regulation of SQS are major foci of current research.

[1]  J. Sacchettini,et al.  Creating Isoprenoid Diversity , 1997, Science.

[2]  Crystal Structure of Human Squalene Synthase , 2000, The Journal of Biological Chemistry.

[3]  I. Shechter,et al.  Molecular cloning, expression, and characterization of the cDNA for the rat hepatic squalene synthase. , 1992, The Journal of biological chemistry.

[4]  I. Shechter,et al.  2.09 – Squalene Synthase , 1999 .

[5]  D. A. Dougherty,et al.  Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp , 1996, Science.

[6]  H. J. Harwood,et al.  HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells. , 1999, Journal of lipid research.

[7]  I. Shechter,et al.  Localization of the squalene synthase gene (FDFT1) to human chromosome 8p22-p23.1. , 1994, Genomics.

[8]  Joseph L Goldstein,et al.  Regulated Intramembrane Proteolysis A Control Mechanism Conserved from Bacteria to Humans , 2000, Cell.

[9]  Roger A. Davis,et al.  Chapter 13 – Isoprenoids, sterols and bile acids , 1996 .

[10]  C. Poulter,et al.  Squalene synthetase. Inhibition by an ammonium analogue of a carbocationic intermediate in the conversion of presqualene pyrophosphate to squalene , 1982 .

[11]  A. Qureshi,et al.  Squalene Synthetase III. MECHANISM OF THE REACTION , 1973 .

[12]  K. Mookhtiar,et al.  Mechanism of inhibition of yeast squalene synthase by substrate analog inhibitors. , 1999, Archives of biochemistry and biophysics.

[13]  R. Hammer,et al.  Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. , 1997, The Journal of clinical investigation.

[14]  H. J. Harwood,et al.  3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors. , 1997, Biochemical pharmacology.

[15]  J. Noel,et al.  Structural basis for cyclic terpene biosynthesis by tobacco 5-epi-aristolochene synthase. , 1997, Science.

[16]  David M. Rothwarf,et al.  The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.

[17]  I. Shechter,et al.  Molecular Cloning and Functional Analysis of the Promoter of the Human Squalene Synthase Gene (*) , 1995, The Journal of Biological Chemistry.

[18]  J C Sacchettini,et al.  Regulation of product chain length by isoprenyl diphosphate synthases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Osborne,et al.  Polyunsaturated Fatty Acids Decrease Expression of Promoters with Sterol Regulatory Elements by Decreasing Levels of Mature Sterol Regulatory Element-binding Protein* , 1998, The Journal of Biological Chemistry.

[20]  I. Shimomura,et al.  Nuclear Sterol Regulatory Element-binding Proteins Activate Genes Responsible for the Entire Program of Unsaturated Fatty Acid Biosynthesis in Transgenic Mouse Liver* , 1998, The Journal of Biological Chemistry.

[21]  I. Shimomura,et al.  Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. , 1999, Current opinion in lipidology.

[22]  P. Edwards,et al.  Effect of site-directed mutagenesis of conserved aspartate and arginine residues upon farnesyl diphosphate synthase activity. , 1993, The Journal of biological chemistry.

[23]  P. Edwards,et al.  YY1 Is a Negative Regulator of Transcription of Three Sterol Regulatory Element-binding Protein-responsive Genes* , 1999, The Journal of Biological Chemistry.

[24]  S. Cornell-Kennon,et al.  Expression, purification, and characterization of the human squalene synthase: use of yeast and baculoviral systems. , 1995, Archives of biochemistry and biophysics.

[25]  F. Karst,et al.  The regulation of activity of main mevalonic acid pathway enzymes: farnesyl diphosphate synthase, 3-hydroxy-3-methylglutaryl-CoA reductase, and squalene synthase in yeast Saccharomyces cerevisiae. , 2000, Biochemical and biophysical research communications.

[26]  R. M. Sandifer,et al.  SQUALENE SYNTHETASE. INHIBITION BY AN AMMONIUM ANALOG OF A CARBOCATIONIC INTERMEDIATE IN THE CONVERSION OF PRESQUALENE PYROPHOSPHATE TO SQUALENE , 1983 .

[27]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[28]  I. Shimomura,et al.  Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Poulter,et al.  Chain elongation in the isoprenoid biosynthetic pathway. , 1997, Current opinion in chemical biology.

[30]  K. Dooley,et al.  A Critical Role for cAMP Response Element-binding Protein (CREB) as a Co-activator in Sterol-regulated Transcription of 3-Hydroxy-3-methylglutaryl Coenzyme A Synthase Promoter* , 1999, The Journal of Biological Chemistry.

[31]  C. Poulter,et al.  Yeast squalene synthase. A mechanism for addition of substrates and activation by NADPH. , 1994, The Journal of biological chemistry.

[32]  D. Danley,et al.  Crystal Structure of Human Squalene Synthase , 2000, The Journal of Biological Chemistry.

[33]  K. Feingold,et al.  Effects of endotoxin and cytokines on lipid metabolism. , 1994, Current opinion in lipidology.

[34]  G. Robinson,et al.  Molecular cloning and characterization of the yeast gene for squalene synthetase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Camara,et al.  Carotenoid biosynthesis: Isolation and characterization of a bifunctional enzyme catalyzing the synthesis of phytoene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Taylor,et al.  Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. , 1993, Journal of lipid research.

[37]  K. Feingold,et al.  Discordant regulation of proteins of cholesterol metabolism during the acute phase response. , 1995, Journal of lipid research.

[38]  Manabu T. Nakamura,et al.  Sterol Regulatory Element Binding Protein-1 Expression Is Suppressed by Dietary Polyunsaturated Fatty Acids , 1999, The Journal of Biological Chemistry.

[39]  M. Brown,et al.  Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. , 1999, The Journal of clinical investigation.

[40]  I. Shechter,et al.  Function-Structure Studies and Identification of Three Enzyme Domains Involved in the Catalytic Activity in Rat Hepatic Squalene Synthase* , 1998, The Journal of Biological Chemistry.

[41]  F. Karst,et al.  Cloning, expression and characterisation of the cDNA encoding human hepatic squalene synthase, and its relationship to phytoene synthase. , 1993, Gene.

[42]  J. Hearst,et al.  Genetics and molecular biology of carotenoid pigment biosynthesis , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  K. Dooley,et al.  Sterol Regulation of 3-Hydroxy-3-Methylglutaryl-coenzyme A Synthase Gene through a Direct Interaction Between Sterol Regulatory Element Binding Protein and the Trimeric CCAAT-binding Factor/Nuclear Factor Y* , 1998, The Journal of Biological Chemistry.

[44]  M. Brown,et al.  Squalene synthetase activity in human fibroblasts: regulation via the low density lipoprotein receptor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[45]  I. Shechter,et al.  SULFOBETAINE ZWITTERIONIC INHIBITORS OF SQUALENE SYNTHASE , 1996 .

[46]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  X. Hua,et al.  Sterol-Regulated Release of SREBP-2 from Cell Membranes Requires Two Sequential Cleavages, One Within a Transmembrane Segment , 1996, Cell.

[48]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[49]  Robert V Farese,et al.  Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. , 1996, Journal of lipid research.

[50]  G. Schulz,et al.  The structure of the membrane protein squalene-hopene cyclase at 2.0 A resolution. , 1999, Journal of molecular biology.

[51]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[52]  C. Poulter,et al.  Yeast farnesyl-diphosphate synthase: site-directed mutagenesis of residues in highly conserved prenyltransferase domains I and II. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Bills,et al.  Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase. , 1995, Annual Review of Microbiology.

[54]  M. Brown,et al.  Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Cane,et al.  Crystal structure of pentalenene synthase: mechanistic insights on terpenoid cyclization reactions in biology. , 1997, Science.

[56]  S. Perrey,et al.  Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase* , 1999, The Journal of Biological Chemistry.

[57]  I. Shechter,et al.  Solubilization, purification, and characterization of a truncated form of rat hepatic squalene synthetase. , 1992, The Journal of biological chemistry.

[58]  C. Poulter Biosynthesis of non-head-to-tail terpenes. Formation of 1'-1 and 1'-3 linkages , 1990 .

[59]  I. Shechter,et al.  Subcellular localization of squalene synthase in rat hepatic cells. Biochemical and immunochemical evidence. , 1993, The Journal of biological chemistry.

[60]  M. Foretz,et al.  Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  H. Kleinig,et al.  Light-dependent regulation of carotenoid biosynthesis occurs at the level of phytoene synthase expression and is mediated by phytochrome in Sinapis alba and Arabidopsis thaliana seedlings. , 1997, The Plant journal : for cell and molecular biology.

[62]  T. Inoue,et al.  Molecular cloning and functional expression of a cDNA for mouse squalene synthase. , 1995, Biochimica et biophysica acta.

[63]  M. Brown,et al.  Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. , 1980, Journal of lipid research.

[64]  J. Flier,et al.  ADD-1 provides major new insight into the mechanism of insulin action. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Goldstein,et al.  Differential Stimulation of Cholesterol and Unsaturated Fatty Acid Biosynthesis in Cells Expressing Individual Nuclear Sterol Regulatory Element-binding Proteins* , 1998, The Journal of Biological Chemistry.

[66]  E. Radisky,et al.  Squalene synthase: steady-state, pre-steady-state, and isotope-trapping studies. , 2000, Biochemistry.

[67]  Jay D. Horton,et al.  Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus* , 1999, The Journal of Biological Chemistry.

[68]  X. Hua,et al.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis , 1994, Cell.

[69]  N. Misawa,et al.  Molecular cloning and expression in Escherichia coli of a cyanobacterial gene coding for phytoene synthase, a carotenoid biosynthesis enzyme , 1992, FEBS letters.

[70]  I. Shechter,et al.  Differential Transcriptional Regulation of the Human Squalene Synthase Gene by Sterol Regulatory Element-binding Proteins (SREBP) 1a and 2 and Involvement of 5′ DNA Sequence Elements in the Regulation* , 1998, Journal of Biological Chemistry.

[71]  Timothy F. Osborne,et al.  Multiple Sequence Elements are Involved in the Transcriptional Regulation of the Human Squalene Synthase Gene* , 1997, The Journal of Biological Chemistry.

[72]  I. Shimomura,et al.  Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Goldstein,et al.  Sterol-resistant transcription in CHO cells caused by gene rearrangement that truncates SREBP-2. , 1994, Genes & development.

[74]  M. Bard,et al.  Transcriptional regulation of the squalene synthase gene (ERG9) in the yeast Saccharomyces cerevisiae. , 1999, Biochimica et biophysica acta.

[75]  T. Hamakubo,et al.  The physiological role of sterol regulatory element-binding protein-2 in cultured human cells. , 1999, Biochimica et biophysica acta.

[76]  K. Feingold,et al.  Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters. , 1997, Journal of lipid research.

[77]  D. Vance,et al.  Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .

[78]  R. Hammer,et al.  Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. , 1997, The Journal of clinical investigation.

[79]  H. Rilling The mechanism of the condensation reactions of cholesterol biosynthesis. Fourth Morton lecture. , 1985, Biochemical Society transactions.

[80]  P. Edwards,et al.  Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein. , 1998, Journal of lipid research.

[81]  T. Tansey,et al.  Squalene synthase: structure and regulation. , 2001, Progress in nucleic acid research and molecular biology.

[82]  T. Osborne,et al.  Different Sterol Regulatory Element-binding Protein-1 Isoforms Utilize Distinct Co-regulatory Factors to Activate the Promoter for Fatty Acid Synthase* , 2000, The Journal of Biological Chemistry.

[83]  J. Sacchettini,et al.  Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-A resolution. , 1994, Biochemistry.

[84]  I. Shimomura,et al.  Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. , 1997, The Journal of clinical investigation.

[85]  R. Hammer,et al.  Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. , 1998, The Journal of clinical investigation.

[86]  H. Rilling,et al.  Purification to homogeneity and some properties of squalene synthetase. , 1988, Archives of Biochemistry and Biophysics.

[87]  P. Procopiou,et al.  Squalene synthase inhibitors: their potential as hypocholesterolaemic agents. , 1996, Progress in medicinal chemistry.

[88]  I. Shechter,et al.  Transcriptional regulation by lovastatin and 25-hydroxycholesterol in HepG2 cells and molecular cloning and expression of the cDNA for the human hepatic squalene synthase. , 1993, The Journal of biological chemistry.

[89]  T. Osborne,et al.  Cooperation by Sterol Regulatory Element-binding Protein and Sp1 in Sterol Regulation of Low Density Lipoprotein Receptor Gene (*) , 1995, The Journal of Biological Chemistry.

[90]  J. Rosenfeld,et al.  Co-stimulation of Promoter for Low Density Lipoprotein Receptor Gene by Sterol Regulatory Element-binding Protein and Sp1 Is Specifically Disrupted by the Yin Yang 1 Protein* , 1999, The Journal of Biological Chemistry.